Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'
February 9, 2023 8:07 AM EST
Stifel analyst Mathew Blackman raised the price target on Cardiovascular Systems (NASDAQ: CSII) to $20.00 (from $18.00) while maintaining a Hold rating.... More
February 9, 2023 7:43 AM EST
Lake Street Capital Markets analyst Brooks O'neil downgraded Cardiovascular Systems (NASDAQ: CSII) from Hold to Sell.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $13.31 yesterday.
...
More
February 9, 2023 6:22 AM EST
Abbott (NYSE: ABT) and Cardiovascular Systems, Inc. (NASDAQ: CSII), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
CSI is a leader in devices for... More
February 9, 2023 4:50 AM EST
Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $63.06 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
...
More
